![Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?: Molecular Therapy - Oncolytics Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?: Molecular Therapy - Oncolytics](https://www.cell.com/cms/attachment/fe936ea0-58b6-483f-892a-906431186e7f/gr4_lrg.jpg)
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?: Molecular Therapy - Oncolytics
![Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success? - ScienceDirect Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S237277052100067X-fx1.jpg)
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success? - ScienceDirect
![Immunotherapy in colorectal cancer: rationale, challenges and potential | Nature Reviews Gastroenterology & Hepatology Immunotherapy in colorectal cancer: rationale, challenges and potential | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41575-019-0126-x/MediaObjects/41575_2019_126_Fig3_HTML.png)
Immunotherapy in colorectal cancer: rationale, challenges and potential | Nature Reviews Gastroenterology & Hepatology
![Immunotherapy for Microsatellite Stable Colorectal Cancers: Challenges and Novel Therapeutic Avenues | American Society of Clinical Oncology Educational Book Immunotherapy for Microsatellite Stable Colorectal Cancers: Challenges and Novel Therapeutic Avenues | American Society of Clinical Oncology Educational Book](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/edbk/2022/edbk.2022.42/edbk_349811/20230421/images/large/edbk_349811-table2.jpeg)
Immunotherapy for Microsatellite Stable Colorectal Cancers: Challenges and Novel Therapeutic Avenues | American Society of Clinical Oncology Educational Book
![Frontiers | Neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer: A new era for anal preservation Frontiers | Neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer: A new era for anal preservation](https://www.frontiersin.org/files/Articles/1067036/fimmu-13-1067036-HTML/image_m/fimmu-13-1067036-t001.jpg)
Frontiers | Neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer: A new era for anal preservation
![Immunotherapy in colorectal cancer: is the long-awaited revolution finally happening? - ScienceDirect Immunotherapy in colorectal cancer: is the long-awaited revolution finally happening? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2468294221001398-gr1.jpg)
Immunotherapy in colorectal cancer: is the long-awaited revolution finally happening? - ScienceDirect
![Immunotherapy in colorectal cancer: rationale, challenges and potential | Nature Reviews Gastroenterology & Hepatology Immunotherapy in colorectal cancer: rationale, challenges and potential | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41575-019-0126-x/MediaObjects/41575_2019_126_Fig1_HTML.png)
Immunotherapy in colorectal cancer: rationale, challenges and potential | Nature Reviews Gastroenterology & Hepatology
![Neoadjuvant PD-1 blockade: a promising nonoperative strategy for mismatch repair–deficient, locally advanced rectal cancer | Signal Transduction and Targeted Therapy Neoadjuvant PD-1 blockade: a promising nonoperative strategy for mismatch repair–deficient, locally advanced rectal cancer | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-022-01216-3/MediaObjects/41392_2022_1216_Fig1_HTML.png)
Neoadjuvant PD-1 blockade: a promising nonoperative strategy for mismatch repair–deficient, locally advanced rectal cancer | Signal Transduction and Targeted Therapy
![Frontiers | Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities Frontiers | Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities](https://www.frontiersin.org/files/Articles/795972/fimmu-13-795972-HTML/image_m/fimmu-13-795972-g001.jpg)
Frontiers | Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities
![Precision oncology in metastatic colorectal cancer — from biology to medicine | Nature Reviews Clinical Oncology Precision oncology in metastatic colorectal cancer — from biology to medicine | Nature Reviews Clinical Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41571-021-00495-z/MediaObjects/41571_2021_495_Fig1_HTML.png)
Precision oncology in metastatic colorectal cancer — from biology to medicine | Nature Reviews Clinical Oncology
![ASCO 2022: 100% Complete Response Rate in MMRd Locally Advanced Rectal Cancer Seen in Pivotal 'Immunoablative' Neoadjuvant Immunotherapy Clinical Trial | Memorial Sloan Kettering Cancer Center ASCO 2022: 100% Complete Response Rate in MMRd Locally Advanced Rectal Cancer Seen in Pivotal 'Immunoablative' Neoadjuvant Immunotherapy Clinical Trial | Memorial Sloan Kettering Cancer Center](https://www.mskcc.org/sites/default/files/styles/large/public/node/246634/3x2/diazcercek-1200x800_0.jpg)
ASCO 2022: 100% Complete Response Rate in MMRd Locally Advanced Rectal Cancer Seen in Pivotal 'Immunoablative' Neoadjuvant Immunotherapy Clinical Trial | Memorial Sloan Kettering Cancer Center
![ASCO GI 2022: Trial evaluating immunotherapy in neoadjuvant setting for the treatment of locally advanced rectal cancer ASCO GI 2022: Trial evaluating immunotherapy in neoadjuvant setting for the treatment of locally advanced rectal cancer](https://www.colorectalcancercanada.com/app/uploads/2022/02/Picture1.png)
ASCO GI 2022: Trial evaluating immunotherapy in neoadjuvant setting for the treatment of locally advanced rectal cancer
![Latest evidence on immune checkpoint inhibitors in metastatic colorectal cancer: A 2022 update - ScienceDirect Latest evidence on immune checkpoint inhibitors in metastatic colorectal cancer: A 2022 update - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1040842822000877-ga1.jpg)